Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Checked against the public recordLast updated Jan 8, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Massachusetts, Worcester
- Interventions being studied
- Behavioral: Tele-Navi LCS
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Is eligible for LDCT for LCS follow-up * Has technology to complete study activities (e.g., video call visit) * English speaker * Has undergone LCS at UMMH * Is overdue for LDCT follow-up Exclusion Criteria: * Has previous diagnosis of lung cancer * Has active cancer diagnosis * Is a nursing home or group care resident * Is pregnant
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- UMass Chan Medical SchoolWorcester, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 8, 2026. Always confirm current availability with the study team.